Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Capital Gp V. Llc Orbimed currently holds 4,975,291 shares of Loxo Oncology, Inc. (LOXO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Gp V. Llc Orbimed has been a net seller of LOXO stock. They have purchased $22.6M and sold $136.9M worth of shares.
Capital Gp V. Llc Orbimed's most recent insider trade was on Oct 23, 2025, when they sold 1,000,000 shares at $1.52 per share.
Capital Gp V. Llc Orbimed serves as Executive at Loxo Oncology, Inc. (LOXO). They have executed 43 insider transactions totaling $159.5M over their tenure at the company.
Capital Gp V. Llc Orbimed holds the position of Executive at Loxo Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Capital Gp V. Llc Orbimed has shown a selling trading pattern, with $22.6M in total purchases and $136.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Capital Gp V. Llc Orbimed was on Mar 3, 2020, when they sold $33.8M worth of INSP shares. This transaction involved 400,000 shares at $84.42 per share.
Capital Gp V. Llc Orbimed currently owns 4,975,291 shares of Loxo Oncology, Inc. (LOXO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Capital Gp V. Llc Orbimed's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Capital Gp V. Llc Orbimed has 43 Form 4 filings on record as an insider at Loxo Oncology, Inc..
Set alerts for Capital Gp V. Llc Orbimed and 40,000+ other insiders.